EDGAR Filing Documents for 0001567619-17-002024

Form 8-K - Current report:

SEC Accession No. 0001567619-17-002024

Filing Date

2017-09-19

Accepted

2017-09-19 16:19:04

Documents

Period of Report

2017-09-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	s001889x1_8k.htm	8-K	23291
2	EXHIBIT 99.1	s001889x1_ex99-1.htm	EX-99.1	9769
3		s001889x1_ex99-1image01.jpg	GRAPHIC	66833
	Complete submission text file	0001567619-17-002024.txt		126424

Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922

Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343

Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)